Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Operating Expenses | 68,861 | 51,196 | 36,833 | 20,683 | 136 |
Operating Income | -68,861 | -51,196 | -36,833 | -20,683 | -136 |
Other Income | 4,396 | 13,511 | 6,196 | -10,986 | 155 |
Pre-tax Income | -64,465 | -37,685 | -30,637 | -31,669 | 18 |
Income Tax | N/A | N/A | N/A | N/A | 16 |
Net Income Continuous | -64,465 | -37,685 | -30,637 | -31,669 | 2 |
Net Income | $-64,465 | $-37,685 | $-30,637 | $-31,669 | $2 |
EPS Basic Total Ops | -6.18 | -10.33 | -26.90 | -51.70 | 0.00 |
EPS Basic Continuous Ops | -6.18 | -10.33 | -26.89 | -51.70 | 0.01 |
EPS Diluted Total Ops | -6.18 | -10.33 | -26.90 | -51.70 | 0.00 |
EPS Diluted Continuous Ops | -6.18 | -10.33 | -26.89 | -51.70 | 0.01 |
EPS Diluted Before Non-Recurring Items | -6.18 | -10.30 | -32.40 | N/A | N/A |
EBITDA(a) | $-67,753 | $-50,221 | $-36,456 | $-20,683 | $-136 |